BeStock  
Markets › Compare › SMMT vs KRYS

SMMT vs KRYS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SMMT · Summit Therapeutics$9.95 ▼ 5.87%
KRYS · Krystal Biotech$308.89 ▼ 2.19%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4982116150183Nov 24, '25May 26, '26Nov 20, '26
  • SMMT -44.2%
  • KRYS +43.7%

Head to head

MetricSMMTKRYS
Price$9.95$308.89
Change today▼ 5.87%▼ 2.19%
Market cap$7.96B$9.15B
Return, 3 months-21.8%-9.6%
Return, year to date-43.1%+25.3%
Return, 1 year-38.5%+45.7%
P/E (TTM)–42.0
P/B14.16.4
P/E percentile vs own 5y44th68th
Dividend yield––
Revenue growth (YoY, latest qtr)–+30.2%
Net profit growth (YoY)+10.1%-20.5%
Gross margin–94.3%
Operating margin–48.4%
Net margin–47.9%
Return on equity-220.0%17.5%
Analyst target vs. price+177.1%+27.3%
Analyst buy share62%100%
RSI (14)3047
30-day volatility109.7%47.9%
Max drawdown, 1 year-62.3%-21.8%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • KRYS is the largest of the group by market value.
  • KRYS has returned the most over the past year.
  • KRYS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top